Annals of internal medicine
-
Randomized Controlled Trial Multicenter Study
Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial.
Studies suggest that dihydropyridine calcium-channel blockers may be associated with reduced risk for Parkinson disease (PD). ⋯ National Institute of Neurological Disorders and Stroke.